ABSTRACT
Increasing awareness of the finite nature of health care resources and the competitiveness of the health care marketplace have resulted in closer scrutiny of costs and benefits of health care ser vices by consumers and payers alike. Manufacturers and marketers of new pharmaceutical and medical technologies are now quite sensitive to the importance of assessing, documenting, and communicating the pharmacoeconomic “value” of their products or programs. Pharmacoeconomics is the study of the monetary and nonmonetary costs and benefits of pharmaceutical us age. Pharmacoeconomic value is inherent when a product produces actual cost savings as well as when a higher cost product is justified by its additional benefits.
